Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs

Author： Sun Yanlin  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.121, Iss.3, 2010-06, pp. : 591-599

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs

By Jin Wei  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 39-48

Springer Publishing Company

Access to resources Recommend Favorite

RNAi-mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug-resistant hepatocellular carcinoma cells to chemotherapy

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 1037-1042

Spandidos Publications

Access to resources Recommend Favorite

Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells

By Zhou Ting  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1299-1306

Springer Publishing Company

Access to resources Recommend Favorite

Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1

By        

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 884-890

Spandidos Publications

Access to resources Recommend Favorite

Chemoprotection Effect of Multidrug Resistance 1 (MDR1) Gene Transfer to Hematopoietic Progenitor Cells and Engrafted in Mice with Cancer Allows Intensified Chemotherapy

By Guo Chunbao   Jin Xianqing  

Cancer Investigation, Vol. 24, Iss. 7, 2006-09 ,pp. : 659-668

Informa Healthcare

Access to resources Recommend Favorite